Genes differentially expressed in CD4+CD56+HN versus c-AML
Fold change . | Description . | Gene symbol . | Distribution of expression according to GNF SymAtlas . | ||
---|---|---|---|---|---|
BDCA4+ dendritic cells . | Central nervous system . | BM CD33+ myeloid cells . | |||
449.97 | T-cell leukemia/lymphoma 1A | TCL1A* | X | ||
255.10 | Immunoglobulin lambda-like polypeptide 1 | IGLL1 | |||
138.92 | Sodium channel, voltage-gated, type III, alpha | SCN3A* | X | ||
109.07 | B-cell novel protein 1 | BCNP1* | X | ||
69.38 | Spi-B transcription factor (Spi-1/PU.1 related) | SPIB | X | ||
37.01 | Hairy and enhancer of split 6 (Drosophila) | HES6* | |||
35.20 | Serine hydrolase-like 2 | SERHL2 | X | ||
34.48 | Hypothetical protein FLJ20716 | FLJ20716 | X | ||
29.86 | Cyclic AMP-regulated phosphoprotein, 21 kDa | ARPP-21 | X | ||
29.00 | RAS, dexamethasone-induced 1 | RASD1 | X | X | |
28.85 | Sidekick homolog 2 (chicken) | SDK2 | X | ||
28.64 | Proapoptotic caspase adaptor protein | PACAP* | X | ||
25.91 | Chromosome 14 open reading frame 175 | C14orf175 | NA | NA | NA |
24.61 | Fc receptor homolog expressed in B cells | FREB | X | ||
24.25 | Deoxynucleotidyltransferase, terminal | TdT | |||
23.56 | Sialic acid binding Ig-like lectin 6 (CD33-like1) | SIGLEC6* | |||
23.33 | WAS protein family, member 1 | WASF1* | X | ||
21.96 | Thymosin-like 8 | TMSL8 | X | ||
21.07 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | PFKFB2 | X | ||
20.69 | Interleukin-28 receptor, alpha (interferon, lambda receptor) | IL28RA | |||
20.32 | Hypothetical protein LOC158402 | LOC158402 | NA | NA | NA |
19.56 | KIAA0746 protein | KIAA0746 | X | ||
19.21 | B-cell linker | BLNK | X | ||
19.13 | Potassium channel, subfamily K, member 17 | KCNK17 | X | ||
18.96 | Protein tyrosine phosphatase, receptor type, S | PTPRS | X | ||
18.64 | G protein-coupled receptor 160 | GPR160* | |||
18.14 | Napsin B aspartic peptidase pseudogene | NAPSB | X | ||
18.08 | Brain expressed X-linked 2 | BEX2 | X | ||
17.77 | Troponin I, skeletal, fast | TNNI2 | |||
17.20 | Runt-related transcription factor 2 | RUNX2* | |||
16.23 | Hypothetical LOC339541 | MGC33556 | X | ||
16.08 | Chromosome 18 open reading frame 1 | C18orf1 | X | ||
15.96 | Serine hydrolase-like | SERHL | X | ||
15.91 | B-cell CLL/lymphoma 11A (zinc finger protein) | BCL11A | X | ||
15.47 | Immunoglobulin J polypeptide | IGJ | X | ||
14.75 | Core-binding factor, runt domain, alpha subunit 2; transl. 3 | CBFA2T3* | X | ||
14.69 | Adenosine deaminase | ADA | X | ||
14.02 | T-cell receptor alpha locus /// T-cell receptor delta locus | TRA /// TRD | X | ||
13.71 | Myosin VI | MYO6 | X | ||
13.41 | PDZ domain containing RING finger 3 | PDZRN3 | X | ||
12.97 | Solute carrier family 38, member 1 | SLC38A1 | X | ||
12.06 | Fas apoptotic inhibitory molecule | FAIM3 | X | ||
11.98 | Selectin L (lymphocyte adhesion molecule 1) | SELL | X | ||
11.06 | Chromosome 3 open reading frame 6 | C3orf6 | X | ||
11.05 | UDP-glucose ceramide glucosyltransferase | UGCG* | X | ||
10.42 | SRY (sex determining region Y)-box 4 | SOX4 | X | ||
10.00 | Protein phosphatase 1K (PP2C domain containing) | PPM1K | X | ||
0.02 | C-type lectin domain family 5, member A | CLEC5A* | X | ||
0.03 | Myeloid-cell nuclear differentiation antigen | MNDA | X | ||
0.04 | C-type lectin domain family 7, member A | CLEC7A | X | ||
0.04 | Regulator of G-protein signaling 18 | RGS18 | X | ||
0.04 | Hypothetical protein FLJ33069 | FLJ33069 | X | ||
0.05 | V-set and immunoglobulin domain containing 4 | VSIG4 | |||
0.05 | Chemokine (C-X3-C motif) receptor 1 | CX3CR1 | |||
0.05 | Ficolin (collagen/fibrinogen domain containing) 1 | FCN1 | X | ||
0.05 | Cathepsin G | CTSG | |||
0.06 | CD33 antigen (gp67) | CD33* | X | ||
0.06 | Calcium channel, voltage-dependent, alpha 2/delta subunit 4 | CACNA2D4 | |||
0.06 | Fc fragment of IgG, high affinity Ia, receptor (CD64) | FCGR1A | X | ||
0.08 | Toll-like receptor 8 | TLR8 | X | ||
0.08 | Complement component 3a receptor 1 | C3AR1 | X | ||
0.09 | Potassium voltage-gated channel, Isk-related family, member 3 | KCNE3 | X | ||
0.10 | CD14 antigen | CD14 | X |
Fold change . | Description . | Gene symbol . | Distribution of expression according to GNF SymAtlas . | ||
---|---|---|---|---|---|
BDCA4+ dendritic cells . | Central nervous system . | BM CD33+ myeloid cells . | |||
449.97 | T-cell leukemia/lymphoma 1A | TCL1A* | X | ||
255.10 | Immunoglobulin lambda-like polypeptide 1 | IGLL1 | |||
138.92 | Sodium channel, voltage-gated, type III, alpha | SCN3A* | X | ||
109.07 | B-cell novel protein 1 | BCNP1* | X | ||
69.38 | Spi-B transcription factor (Spi-1/PU.1 related) | SPIB | X | ||
37.01 | Hairy and enhancer of split 6 (Drosophila) | HES6* | |||
35.20 | Serine hydrolase-like 2 | SERHL2 | X | ||
34.48 | Hypothetical protein FLJ20716 | FLJ20716 | X | ||
29.86 | Cyclic AMP-regulated phosphoprotein, 21 kDa | ARPP-21 | X | ||
29.00 | RAS, dexamethasone-induced 1 | RASD1 | X | X | |
28.85 | Sidekick homolog 2 (chicken) | SDK2 | X | ||
28.64 | Proapoptotic caspase adaptor protein | PACAP* | X | ||
25.91 | Chromosome 14 open reading frame 175 | C14orf175 | NA | NA | NA |
24.61 | Fc receptor homolog expressed in B cells | FREB | X | ||
24.25 | Deoxynucleotidyltransferase, terminal | TdT | |||
23.56 | Sialic acid binding Ig-like lectin 6 (CD33-like1) | SIGLEC6* | |||
23.33 | WAS protein family, member 1 | WASF1* | X | ||
21.96 | Thymosin-like 8 | TMSL8 | X | ||
21.07 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | PFKFB2 | X | ||
20.69 | Interleukin-28 receptor, alpha (interferon, lambda receptor) | IL28RA | |||
20.32 | Hypothetical protein LOC158402 | LOC158402 | NA | NA | NA |
19.56 | KIAA0746 protein | KIAA0746 | X | ||
19.21 | B-cell linker | BLNK | X | ||
19.13 | Potassium channel, subfamily K, member 17 | KCNK17 | X | ||
18.96 | Protein tyrosine phosphatase, receptor type, S | PTPRS | X | ||
18.64 | G protein-coupled receptor 160 | GPR160* | |||
18.14 | Napsin B aspartic peptidase pseudogene | NAPSB | X | ||
18.08 | Brain expressed X-linked 2 | BEX2 | X | ||
17.77 | Troponin I, skeletal, fast | TNNI2 | |||
17.20 | Runt-related transcription factor 2 | RUNX2* | |||
16.23 | Hypothetical LOC339541 | MGC33556 | X | ||
16.08 | Chromosome 18 open reading frame 1 | C18orf1 | X | ||
15.96 | Serine hydrolase-like | SERHL | X | ||
15.91 | B-cell CLL/lymphoma 11A (zinc finger protein) | BCL11A | X | ||
15.47 | Immunoglobulin J polypeptide | IGJ | X | ||
14.75 | Core-binding factor, runt domain, alpha subunit 2; transl. 3 | CBFA2T3* | X | ||
14.69 | Adenosine deaminase | ADA | X | ||
14.02 | T-cell receptor alpha locus /// T-cell receptor delta locus | TRA /// TRD | X | ||
13.71 | Myosin VI | MYO6 | X | ||
13.41 | PDZ domain containing RING finger 3 | PDZRN3 | X | ||
12.97 | Solute carrier family 38, member 1 | SLC38A1 | X | ||
12.06 | Fas apoptotic inhibitory molecule | FAIM3 | X | ||
11.98 | Selectin L (lymphocyte adhesion molecule 1) | SELL | X | ||
11.06 | Chromosome 3 open reading frame 6 | C3orf6 | X | ||
11.05 | UDP-glucose ceramide glucosyltransferase | UGCG* | X | ||
10.42 | SRY (sex determining region Y)-box 4 | SOX4 | X | ||
10.00 | Protein phosphatase 1K (PP2C domain containing) | PPM1K | X | ||
0.02 | C-type lectin domain family 5, member A | CLEC5A* | X | ||
0.03 | Myeloid-cell nuclear differentiation antigen | MNDA | X | ||
0.04 | C-type lectin domain family 7, member A | CLEC7A | X | ||
0.04 | Regulator of G-protein signaling 18 | RGS18 | X | ||
0.04 | Hypothetical protein FLJ33069 | FLJ33069 | X | ||
0.05 | V-set and immunoglobulin domain containing 4 | VSIG4 | |||
0.05 | Chemokine (C-X3-C motif) receptor 1 | CX3CR1 | |||
0.05 | Ficolin (collagen/fibrinogen domain containing) 1 | FCN1 | X | ||
0.05 | Cathepsin G | CTSG | |||
0.06 | CD33 antigen (gp67) | CD33* | X | ||
0.06 | Calcium channel, voltage-dependent, alpha 2/delta subunit 4 | CACNA2D4 | |||
0.06 | Fc fragment of IgG, high affinity Ia, receptor (CD64) | FCGR1A | X | ||
0.08 | Toll-like receptor 8 | TLR8 | X | ||
0.08 | Complement component 3a receptor 1 | C3AR1 | X | ||
0.09 | Potassium voltage-gated channel, Isk-related family, member 3 | KCNE3 | X | ||
0.10 | CD14 antigen | CD14 | X |
Genes differentially expressed in CD4+CD56+HN versus c-AML resulting from supervised analysis applying a fold change difference of at least 10. Expression distribution according to the Genomics Institute of the Novartis Research Foundation (GNF) SymAtlas is indicated (X). Bold indicates genes seemingly characteristic for CD4+CD56+HN (for details see “Putative oncogenes” and “Novel membrane-bound markers for CD4+CD56+HN”).
NA indicates not available.
Genes verified by real-time RT-PCR.